Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in Asians with nonvalvular atrial fibrillation
YH Chan, LC See, HT Tu, YH Yeh… - Journal of the …, 2018 - Am Heart Assoc
Background Whether non–vitamin K antagonist oral anticoagulants (NOAC s) are superior to
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
[PDF][PDF] Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
YH Chan, LC See, HT Tu, YH Yeh, SH Chang, LS Wu… - 2018 - researchgate.net
Background-—Whether non–vitamin K antagonist oral anticoagulants (NOACs) are superior
to warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
to warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation.
YH Chan, LC See, HT Tu, YH Yeh… - Journal of the …, 2018 - europepmc.org
Background Whether non–vitamin K antagonist oral anticoagulants (NOAC s) are superior to
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
YH Chan, LC See, HT Tu, YH Yeh… - Journal of the …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Whether non-vitamin K antagonist oral anticoagulants (NOACs) are superior to
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
[PDF][PDF] Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
YH Chan, LC See, HT Tu, YH Yeh, SH Chang, LS Wu… - 2018 - pdfs.semanticscholar.org
Background-—Whether non–vitamin K antagonist oral anticoagulants (NOACs) are superior
to warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
to warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
[HTML][HTML] Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
YH Chan, LC See, HT Tu, YH Yeh… - Journal of the …, 2018 - ncbi.nlm.nih.gov
Background Whether non–vitamin K antagonist oral anticoagulants (NOAC s) are superior to
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation.
YH Chan, LC See, HT Tu, YH Yeh… - Journal of the …, 2018 - europepmc.org
Background Whether non–vitamin K antagonist oral anticoagulants (NOAC s) are superior to
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …
warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and …